High Quality Evidence of Chinese Lupus Nephritis (HELP)
NCT03001973 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 5000
Last updated 2020-10-22
Summary
The investigators are registering LN patients at recruited hospitals and developing a LN database in China. Patients will be follow-up every year, and both baseline and follow-up information will be entered into the registration system.
Conditions
Interventions
- OTHER
-
No Intervention
Registration of all LN patients in the First Affiliated Hospital of Sun Yat-sen University and other hospitals which have signed the contract in China.
Sponsors & Collaborators
-
Sun Yat-sen University
lead OTHER
Eligibility
- Min Age
- 14 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2013-11-30
- Primary Completion
- 2026-12-31
- Completion
- 2026-12-31
Countries
- China
Study Locations
More Related Trials
-
Long-Term Study of Multi-target Therapy as Maintenance Treatment for Lupus Nephritis
NCT01056237 ·Status: COMPLETED ·Phase: NA
-
Renal Survival in Patients with Lupus Nephritis
NCT06588192 ·Status: NOT_YET_RECRUITING
-
Pre-emptive Treatments in Lupus Nephritis Patients With Serological Reactivation
NCT04870359 ·Status: COMPLETED ·Phase: NA
-
Evaluation of Patients With Lupus Nephritis Using Kidney MRI (Magnetic Resonance Imaging)
NCT06445127 ·Status: TERMINATED
-
Lupus Nephritis Biomarker Study: Baseline Characteristics of Patients
NCT01470183 ·Status: COMPLETED
-
Metformin In Prevention of Lupus Nephritis
NCT04145687 ·Status: UNKNOWN ·Phase: PHASE4
-
Predictors of Remission and Renal Outcomes in Lupus Nephritis in Assuit University Hospitals.
NCT06228222 ·Status: NOT_YET_RECRUITING
-
T Regulatory Cells IN LUPUS NEPHRITIS
NCT06428539 ·Status: NOT_YET_RECRUITING
-
The Expression Profile of New Complement Components in Childhood Lupus Nephritis
NCT05082363 ·Status: UNKNOWN
-
Concentration-controlled Therapy of Mycophenolate Mofetil (MMF) in Proliferative Lupus Nephritis
NCT01042457 ·Status: COMPLETED ·Phase: PHASE3
-
Disease and Biomarker Profiling of Chinese Lupus Nephritis
NCT06210464 ·Status: NOT_YET_RECRUITING
-
The Mechanisms and Significances of Synergistic Effects of Mycophenolic Acid and LPS on IL-1β Secretion by Mononuclear
NCT02435368 ·Status: UNKNOWN
-
CNCT19 Cell Injection for Refractory Systemic Lupus Erythematosus
NCT05930314 ·Status: UNKNOWN ·Phase: EARLY_PHASE1
-
Leflunomide Versus Azathioprine for Maintenance Therapy of Lupus Nephritis
NCT01172002 ·Status: UNKNOWN ·Phase: NA
-
The Efficacy and Safety of Telitacicept and Belimumab in Active Lupus Nephritis in the Real World: a Prospective Cohort Study
NCT05588830 ·Status: UNKNOWN
-
Disease Activity Biomarkers in Patients With Systemic Lupus Erythematosus
NCT05443516 ·Status: RECRUITING
-
Comparing Efficacy and Safety of Telitacicept and Belimumab in Lupus Nephritis: A Retrospective Multicenter Cohort Study.
NCT07031674 ·Status: COMPLETED
-
A Study of Telitacicept in Lupus Nephritis
NCT05680480 ·Status: RECRUITING ·Phase: PHASE2
-
Renal Assessment for Early Detection of Renal Impairment in Systemic Sclerosis and Systemic Lupus Erythematosus Patients
NCT06287125 ·Status: NOT_YET_RECRUITING
-
Functional MRI in Lupus Nephritis
NCT01731054 ·Status: COMPLETED
-
Induction Treatment of Proliferative Lupus Nephritis With Leflunomide Combined With Prednisone
NCT00268567 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Prognostic Factors for Treatment Responses in Patients With Active Lupus Nephritis at Sohag University Hospital
NCT04756492 ·Status: UNKNOWN
-
Autologous Hematopoietic Stem Cell Transplantation for Refractory Lupus Nephritis
NCT03828071 ·Status: COMPLETED ·Phase: NA
-
Efficacy and Safety of Artesunate Plus Standard of Care in Active Lupus Nephritis
NCT03214731 ·Status: UNKNOWN ·Phase: PHASE4
-
Interferon Pathway Activation in Monogenic and Nonmonogenic Forms of Pediatric SLE
NCT06586710 ·Status: RECRUITING ·Phase: NA